Search results
Results from the WOW.Com Content Network
Chloramphenicol is a broad-spectrum antibiotic that typically stops bacterial growth by stopping the production of proteins. [5] Chloramphenicol was discovered after being isolated from Streptomyces venezuelae in 1947. [8] Its chemical structure was identified and it was first synthesized in 1949.
Form I-130, Petition for Alien Relative, 2015. Form I-130, Petition for Alien Relative is a form submitted to the United States Citizenship and Immigration Services (or, in the rare case of Direct Consular Filing, to a US consulate or embassy abroad) by a United States citizen or Lawful Permanent Resident petitioning for an immediate or close relative (who is not currently a United States ...
Direct Consular Filing (DCF) is a process related to immigration to the United States whereby Form I-130 (Petition for Alien Relative), I-360 (Petition for Amerasian, Widow(er), or Special Immigrant), or I-600 (Petition to Classify Orphan as an Immediate Relative), is filed with a United States embassy or consulate in another country rather than with the United States Citizenship and ...
Since the syndrome is due to the accumulation of chloramphenicol, the signs and symptoms are dose related. [10] According to Kasten's review published in the Mayo Clinic Proceedings, a serum concentration of more than 50 μg/mL is a warning sign, [10] while Hammett-Stabler and John states that the common therapeutics peak level is 10-20 μg/mL and is expected to achieve after 0.5-1.5 hours of ...
Registry of Toxic Effects of Chemical Substances (RTECS) is a database of toxicity information compiled from the open scientific literature without reference to the validity or usefulness of the studies reported.
IARC group 2A agents are substances and exposure circumstances that have been classified as probable carcinogens by the International Agency for Research on Cancer (IARC). [1] This designation is applied when there is limited evidence of carcinogenicity in humans, as well as sufficient evidence of carcinogenicity in experimental animals .
A Notice of Intent to Revoke (NOIR) is a communication sent by the United States Citizenship and Immigration Services to a petitioner about a previously approved petition, telling him or her that the USCIS intends to revoke the petition, along with the reasons for revocation, and giving the petitioner a fixed amount of time to respond. [1]
If the Form 356h is missing information, the FDA will reply within 74 days. [3] A BLA asserts that the product is "safe, pure, and potent", the manufacturing facilities are inspectable, and each package of the product bears the license number. Statutory standards for BLA approval are largely the same as those for New Drug Application approval